Abstract
Background
Epidemiologic studies have identified cholecystectomy as a possible risk factor for cancers in Western countries. The aim of this study was to estimate the risk of hepato-biliary cancer after cholecystectomy in Taiwan.
Methods
Based on the Taiwan National Health Insurance Research Database, 2,590 cholecystectomized patients without prior cancers in the period 1996–2008 were identified from a cohort dataset of 1,000,000 randomly sampled individuals. The standard incidence ratio (SIR) of each cancer was calculated.
Results
After a median follow-up of 4.82 years, 67 liver cancer and 17 biliary tract cancer patients were diagnosed. Patients who received cholecystectomy had higher risks of liver cancer (SIR, 3.29) and biliary tract cancer (SIR, 8.50). Cholecystectomized patients aged ≤60 years had higher risks of liver cancer (SIR, 11.14) and biliary tract cancer (SIR, 55.86) compared to those aged >60 years (SIR, 2.31 and 5.67). Female cholecystectomized patients had higher risks of liver cancer (SIR, 4.18) and biliary tract cancer (SIR, 10.56) than males (SIR, 2.96 and 7.26). Cholecystectomized patients with cirrhosis had higher SIR of liver cancer than patients without cirrhosis (SIR, 33.84 vs. 1.41).
Conclusions
Cholecystectomy may be associated with an increased risk of hepato-biliary cancer. Further and regular surveillance should be performed on such patients.
Similar content being viewed by others
Abbreviations
- DM:
-
Diabetes mellitus
- NHIRD:
-
National Health Insurance Research Database
- SIR:
-
standardized incidence ratio
- CI:
-
confidence interval
- ICD-9-CM:
-
International Classification of Diseases, 9th Revision, Clinical Modification
References
Bates T, Harrison M, Lowe D, Lawson C, Padley N. Longitudinal study of gall stone prevalence at necropsy. Gut 1992, 33:103–107.
Halldestam I, Enell EL, Kullman E, Borch K. Development of symptoms and complications in individuals with asymptomatic gallstones. Br J Surg 2004, 91:734–738.
Beckingham IJ. ABC of diseases of liver, pancreas, and biliary system. Gallstone disease. BMJ 2001, 322:91–94.
Chen CY, Lu CL, Huang YS, Tam TN, Chao Y, Chang FY, Lee SD. Age is one of the risk factors in developing gallstone disease in Taiwan. Age Ageing 1998, 27:437–441.
Chen CH, Huang MH, Yang JC, Nien CK, Etheredge GD, Yang CC, Yeh YH, Wu HS, Chou DA, Yueh SK. Prevalence and risk factors of gallstone disease in an adult population of Taiwan: an epidemiological survey. J Gastroenterol Hepatol 2006, 21:1737–1743.
Owings MF, Kozak LJ. Ambulatory and inpatient procedures in the United States, 1996. Vital Health Stat 13 1998(139):1–119.
Huang J, Chang CH, Wang JL, Kuo HK, Lin JW, Shau WY, Lee PH. Nationwide epidemiological study of severe gallstone disease in Taiwan. BMC Gastroenterol 2009, 9:63.
Lagergren J, Ye W, Ekbom A. Intestinal cancer after cholecystectomy: is bile involved in carcinogenesis? Gastroenterology 2001, 121:542–547.
Schernhammer ES, Leitzmann MF, Michaud DS, Speizer FE, Giovannucci E, Colditz GA, Fuchs CS. Cholecystectomy and the risk for developing colorectal cancer and distal colorectal adenomas. Br J Cancer 2003, 88:79–83.
Shao T, Yang YX. Cholecystectomy and the risk of colorectal cancer. Am J Gastroenterol 2005, 100:1813–1820.
Freedman J, Ye W, Naslund E, Lagergren J. Association between cholecystectomy and adenocarcinoma of the esophagus. Gastroenterology 2001, 121:548–553.
Lagergren J, Mattsson F. Cholecystectomy as a risk factor for oesophageal adenocarcinoma. Br J Surg 2011, 98:1133–1137.
Lin G, Zeng Z, Wang X, Wu Z, Wang J, Wang C, Sun Q, Chen Y, Quan H. Cholecystectomy and risk of pancreatic cancer: a meta-analysis of observational studies. Cancer Causes Control 2012, 23:59–67.
Chow WH, Johansen C, Gridley G, Mellemkjaer L, Olsen JH, Fraumeni JF, Jr. Gallstones, cholecystectomy and risk of cancers of the liver, biliary tract and pancreas. Br J Cancer 1999, 79:640–644.
Tanaka M, Ikeda S, Nakayama F. Change in bile duct pressure responses after cholecystectomy: loss of gallbladder as a pressure reservoir. Gastroenterology 1984, 87:1154–1159.
Lagergren J, Mattsson F, El-Serag H, Nordenstedt H. Increased risk of hepatocellular carcinoma after cholecystectomy. Br J Cancer 2011, 105:154–156.
Goldacre MJ, Abisgold JD, Seagroatt V, Yeates D. Cancer after cholecystectomy: record-linkage cohort study. Br J Cancer 2005, 92:1307–1309.
Ekbom A, Hsieh CC, Yuen J, Trichopoulos D, McLaughlin JK, Lan SJ, Adami HO. Risk of extrahepatic bileduct cancer after cholecystectomy. Lancet 1993, 342:1262–1265.
Urbach DR, Swanstrom LL, Khajanchee YS, Hansen PD. Incidence of cancer of the pancreas, extrahepatic bile duct and ampulla of Vater in the United States, before and after the introduction of laparoscopic cholecystectomy. Am J Surg 2001, 181:526–528.
Ye W, Lagergren J, Nyren O, Ekbom A. Risk of pancreatic cancer after cholecystectomy: a cohort study in Sweden. Gut 2001, 49:678–681.
Lagergren J, Mattsson F. Cholecystectomy and risk of laryngeal and pharyngeal cancer. Int J Cancer 2012, 130:2211–2214.
Hwang CY, Chen YJ, Lin MW, Chen TJ, Chu SY, Chen CC, Lee DD, Chang YT, Wang WJ, Liu HN. Cancer risk in patients with allergic rhinitis, asthma and atopic dermatitis: a nationwide cohort study in Taiwan. Int J Cancer 2012, 130:1160–1167.
Lin CC, Lai MS, Syu CY, Chang SC, Tseng FY. Accuracy of diabetes diagnosis in health insurance claims data in Taiwan. J Formos Med Assoc 2005, 104:157–163.
Cheng CL, Kao YH, Lin SJ, Lee CH, Lai ML. Validation of the National Health Insurance Research Database with ischemic stroke cases in Taiwan. Pharmacoepidemiol Drug Saf 2011, 20:236–242.
Luo JC, Leu HB, Huang KW, Huang CC, Hou MC, Lin HC, Lee FY, Lee SD. Incidence of bleeding from gastroduodenal ulcers in patients with end-stage renal disease receiving hemodialysis. CMAJ 2011, 183: E1345-1351.
Huang KW, Luo JC, Leu HB, Lin HC, Lee FY, Chan WL, Lin SJ, Chen JW, Chang FY. Chronic obstructive pulmonary disease: an independent risk factor for peptic ulcer bleeding: a nationwide population-based study. Aliment Pharmacol Ther 2012, 35:796–802.
Kao WY, Hwang CY, Chang YT, Su CW, Hou MC, Lin HC, Lee FY, Lee SD, Wu JC. Cancer risk in patients with pyogenic liver abscess: a nationwide cohort study. Aliment Pharmacol Ther 2012 ; 36: 467–476
Hung SC, Liao KF, Lai SW, Li CI, Chen WC. Risk factors associated with symptomatic cholelithiasis in Taiwan: a population-based study. BMC Gastroenterol 2011, 11:111.
Luo JC, Leu HB, Hou MC, Huang CC, Lin HC, Lee FY, Chang FY, Chan WL, Lin SJ, Chen JW. Cirrhotic patients at increased risk of peptic ulcer bleeding: a nationwide population-based cohort study. Aliment Pharmacol Ther 2012; 36: 542–550.
Lin HL, Lin HC, Lin CC. Increased risk of colorectal cancer among patients with biliary tract inflammation: a 5-year follow-up study. Int J Cancer 2011, 128:447–452.
Gurusamy KS, Davidson BR. Surgical treatment of gallstones. Gastroenterol Clin North Am 2010, 39:229–244, viii.
Rustagi T, Dasanu CA. Risk factors for gallbladder cancer and cholangiocarcinoma: similarities, differences and updates. J Gastrointest Cancer 2012, 43:137–147.
Thomsen RW, Thomsen HF, Norgaard M, Cetin K, McLaughlin JK, Tarone RE, Fryzek JP, Sorensen HT. Risk of cholecystitis in patients with cancer: a population-based cohort study in Denmark. Cancer 2008, 113:3410–3419.
Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell 2010, 140:883–899.
Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature 2008, 454:436–444.
Sheen IS, Liaw YF. The prevalence and incidence of cholecystolithiasis in patients with chronic liver diseases: a prospective study. Hepatology 1989, 9:538–540.
El-Serag HB. Hepatocellular carcinoma. N Engl J Med 2011, 365:1118–1127.
Chen HF, Chen P, Li CY. Risk of malignant neoplasms of liver and biliary tract in diabetic patients with different age and sex stratifications. Hepatology 2010, 52:155–163.
Anisimov VN. Biology of aging and cancer. Cancer Control 2007, 14:23–31.
Yang HI, Sherman M, Su J, Chen PJ, Liaw YF, Iloeje UH, Chen CJ. Nomograms for risk of hepatocellular carcinoma in patients with chronic hepatitis B virus infection. J Clin Oncol 2010, 28:2437–2444.
Trichopoulos D, Bamia C, Lagiou P, Fedirko V, Trepo E, Jenab M, Pischon T, Nothlings U, Overved K, Tjonneland A et al. Hepatocellular carcinoma risk factors and disease burden in a European cohort: a nested case–control study. J Natl Cancer Inst 2011, 103:1686–1695.
Tyson GL, El-Serag HB. Risk factors for cholangiocarcinoma. Hepatology 2011, 54:173–184.
Wen CP, Tsai SP, Chung WS. A 10-year experience with universal health insurance in Taiwan: measuring changes in health and health disparity. Ann Intern Med 2008, 148:258–267.
Acknowledgments
This study is based in part on data from the National Health Insurance Research Database provided by the Bureau of National Health Insurance, Department of Health and managed by the National Health Research Institutes. The interpretation and conclusions contained herein do not represent those of the Bureau of National Health Insurance, Department of Health, or National Health Research Institutes.
Contributions
Drs. WY Kao and CY Hwang contributed equally to this work.
Disclosures
There is no potential conflict of interest involved in this paper.
Grant Support
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kao, WY., Hwang, CY., Su, CW. et al. Risk of Hepato-Biliary Cancer After Cholecystectomy: a Nationwide Cohort Study. J Gastrointest Surg 17, 345–351 (2013). https://doi.org/10.1007/s11605-012-2090-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11605-012-2090-4